Skip to main content
Top
Published in: Medical Oncology 2/2012

01-06-2012 | Original Paper

Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment

Authors: O. O. Faluyi, S. P. Masinghe, R. L. Hayward, S. Clive

Published in: Medical Oncology | Issue 2/2012

Login to get access

Abstract

Estimation of renal function is crucial to guidance of systemic chemotherapy. With stable creatinine levels, the glomerular filtration rate (GFR) is often estimated from a single measurement of serum creatinine. We compared accuracy of the Cockroft and Gault (C&G), modifying diet in renal diseases (MDRD) and Wright estimates in Oncology patients with renal impairment. Analysis was carried out on the basis of monodentate platinum treatment as the nephrotoxic mechanism of these drugs may affect accuracy of these estimates. Sixty-two consecutive patients with stable creatinine levels who had isotopic GFR measurement of ≤ 60 ml min−1 at a regional cancer center were reviewed. Twenty-nine were on monodentate platinum treatment. Isotopic GFR was compared with estimated GFR by the three equations. We defined three categories of estimate based on the fractional difference from isotopic GFR: ‘perfect’ (< 10%), ‘reasonable’ (≥ 10% but < 30%) and ‘poor’ (≥ 30%). There was a trend toward provision of more perfect estimates by the MDRD equation particularly in patients on monodentate platinum treatment. Similar numbers had poor estimates from either of these equations, particularly at extremes of body weight. The MDRD formula may be the most accurate of these equations in Oncology patients with renal impairment, particularly with monodentate platinum treatment.
Literature
1.
go back to reference Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.PubMedCrossRef Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.PubMedCrossRef
2.
go back to reference Wright, et al. Estimation of glomerular filtration rate in cancer patients. Brit J Cancer. 2001;84(4):452–9.PubMedCrossRef Wright, et al. Estimation of glomerular filtration rate in cancer patients. Brit J Cancer. 2001;84(4):452–9.PubMedCrossRef
3.
go back to reference Kvale, et al. History of cancer and mortality in community-dwelling older adults. Cancer Epidemiol. 2010 [Epub: Aug 2010]. Kvale, et al. History of cancer and mortality in community-dwelling older adults. Cancer Epidemiol. 2010 [Epub: Aug 2010].
4.
go back to reference Launay-Vacher, et al. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Med Sci Monit. 2004;10(5):209–12. Launay-Vacher, et al. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Med Sci Monit. 2004;10(5):209–12.
5.
go back to reference Levey, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.PubMed Levey, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.PubMed
6.
go back to reference Stevens, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007;18(10):2749–57.PubMedCrossRef Stevens, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007;18(10):2749–57.PubMedCrossRef
7.
go back to reference Barraclough, et al. Estimation of renal function – what is appropriate in cancer patients? Clin Oncol. 2008;20(10):721–6.CrossRef Barraclough, et al. Estimation of renal function – what is appropriate in cancer patients? Clin Oncol. 2008;20(10):721–6.CrossRef
8.
go back to reference Harland, et al. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. Cancer Res. 1984;44(4):1693–7.PubMed Harland, et al. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. Cancer Res. 1984;44(4):1693–7.PubMed
9.
go back to reference de Lemos, et al. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies. Gynecol Oncol. 2006;103(3):1063–9.PubMedCrossRef de Lemos, et al. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies. Gynecol Oncol. 2006;103(3):1063–9.PubMedCrossRef
10.
go back to reference Nonclercq, et al. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin. Exp Mol Pathol. 1989;51(2):123–40.PubMedCrossRef Nonclercq, et al. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin. Exp Mol Pathol. 1989;51(2):123–40.PubMedCrossRef
11.
go back to reference Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303–11.PubMed Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303–11.PubMed
12.
go back to reference Waller DG, Keast CM, Fleming JS, Ackery DM. Measurement of glomerular filtration rate with technetium-99m DTPA: comparison of plasma clearance techniques. J Nucl Med. 1987;28(30):372–7.PubMed Waller DG, Keast CM, Fleming JS, Ackery DM. Measurement of glomerular filtration rate with technetium-99m DTPA: comparison of plasma clearance techniques. J Nucl Med. 1987;28(30):372–7.PubMed
13.
go back to reference Jodrell, et al. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol. 1992;10(4):520–8.PubMed Jodrell, et al. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol. 1992;10(4):520–8.PubMed
14.
go back to reference Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med. 1988;84(6):1053–60.PubMedCrossRef Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med. 1988;84(6):1053–60.PubMedCrossRef
15.
go back to reference Martin J, et al. Improvement of the Cockcroft-Gault equation for predicting glomerular filtration in cancer patients. Bull Cancer. 1998;85:631–6.PubMed Martin J, et al. Improvement of the Cockcroft-Gault equation for predicting glomerular filtration in cancer patients. Bull Cancer. 1998;85:631–6.PubMed
16.
go back to reference Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol. 1998;9(10):1053–71.PubMedCrossRef Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol. 1998;9(10):1053–71.PubMedCrossRef
17.
go back to reference Raj GV, Iasonos A, Herr H, Donat SM. Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer. J Clin Oncol. 2006;24(19):3095–100.PubMedCrossRef Raj GV, Iasonos A, Herr H, Donat SM. Formulas calculating creatinine clearance are inadequate for determining eligibility for cisplatin-based chemotherapy in bladder cancer. J Clin Oncol. 2006;24(19):3095–100.PubMedCrossRef
18.
go back to reference Dobyan DC. Long-term consequences of cis-platinum-induced renal injury: a structural and functional study. Anat Rec. 1985;212(3):239–45.PubMedCrossRef Dobyan DC. Long-term consequences of cis-platinum-induced renal injury: a structural and functional study. Anat Rec. 1985;212(3):239–45.PubMedCrossRef
19.
go back to reference Li, et al. Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells. Am J Physiol Renal Physiol. 2010;299(1):F167–77.PubMedCrossRef Li, et al. Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells. Am J Physiol Renal Physiol. 2010;299(1):F167–77.PubMedCrossRef
Metadata
Title
Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment
Authors
O. O. Faluyi
S. P. Masinghe
R. L. Hayward
S. Clive
Publication date
01-06-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9824-0

Other articles of this Issue 2/2012

Medical Oncology 2/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.